Viewing Study NCT02936102


Ignite Creation Date: 2025-12-25 @ 3:54 AM
Ignite Modification Date: 2026-02-21 @ 10:58 AM
Study NCT ID: NCT02936102
Status: TERMINATED
Last Update Posted: 2025-11-14
First Post: 2016-09-15
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of FAZ053 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies.
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module